Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Macau

About this trial

The current project is dedicated to creating a comprehensive cognitive and neural assessment platform and corresponding norms tailored specifically to the older adults in Macau.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Must be a local adult resident of Macau

Age above 50 years for older adult cohort

Younger adults individuals above 18 will be included as control comparators

Disqualifiers

History of neurological injury or disease

Current use of medications that affect brain function or blood flow

Contraindications to MRI scanning, such as the presence of an electric/mechanical implant or device (e.g., pacemaker)

Claustrophobia

Trial population

Adults above 50 years old from the Macau local community.

Trial design

Design model

Ecologic or community

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 2 trial groups
Group A: Group 1
Group B: Group 2

Trial outcomes

Primary outcomes

1

Normative Data for the Montreal Cognitive Assessment - Chinese (Hong Kong) version

The MoCA will be administered to derive a normative data set representative of the older adult population in Macau.

Time frame
From February 2024 to January 2026
2

Normative Data for the Mini-Mental State Examination (MMSE)

The MMSE will be administered to derive a normative data set representative of the older adult population in Macau.

Time frame
From February 2024 to January 2026
3

Normative Scores for Computerized Neuropsychological Tasks

Neuropsychological tasks will be employed to measure selective attention capacity and processing speed in the study cohort. These tasks will provide quantifiable data on the efficiency and accuracy of cognitive processing. The collective performance on these tasks will be used to establish benchmark values - including means, medians, and ranges - that define the normative standards for these cognitive abilities in the population.

Time frame
From February 2024 to January 2026

Secondary outcomes

1

Neural Activation Patterns During Cognitive Tasks as Revealed by Functional Magnetic Resonance Imaging (fMRI)

fMRI data will be collected to identify patterns of neural activation associated with cognitive task performance.

Time frame
From February 2024 to January 2026
2

Cerebral Hemodynamics Assessed Through Functional Near-Infrared Spectroscopy (fNIRS)

fNIRS will be employed to measure cerebral blood flow and oxygenation during cognitive tasks.

Time frame
From February 2024 to January 2026
3

Electrophysiological Correlates of Cognitive Activity as Measured by Electroencephalography (EEG)

EEG will be utilized to record the electrical activity of the brain during cognitive tasks. Key outcome metrics will include event-related potentials (ERPs) amplitudes and latencies, with mean values and variability measures reported for the cohort.

Time frame
From February 2024 to January 2026

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: